Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Carreño-Tarragona G, Álvarez-Larrán A, Hernández-Boluda JC, Ayala R, Cross NCP. Carreño-Tarragona G, et al. Among authors: alvarez larran a. Blood Adv. 2023 Nov 14;7(21):6705-6706. doi: 10.1182/bloodadvances.2023011103. Blood Adv. 2023. PMID: 37672387 Free PMC article. No abstract available.
Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M, Alvarez-Larrán A, Colomer D, López-Guerra M, García-Criado MÁ, Mezzano G, Belmonte E, Olivas P, Soy G, Cervantes F, Darnell A, Ferrusquía-Acosta J, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. Magaz M, et al. J Hepatol. 2021 Jan;74(1):89-95. doi: 10.1016/j.jhep.2020.06.045. Epub 2020 Jul 15. J Hepatol. 2021. PMID: 32679300
Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP. Peñalver FJ, et al. Ann Hematol. 2006 Jun;85(6):400-6. doi: 10.1007/s00277-005-0073-1. Epub 2006 Mar 21. Ann Hematol. 2006. PMID: 16550390
[Subcutaneous panniculitic T-cell lymphoma].
Alvarez-Larrán A, López-Guillermo A, Miquel R, Montserrat E. Alvarez-Larrán A, et al. Med Clin (Barc). 1999 Jun 26;113(3):117. Med Clin (Barc). 1999. PMID: 10464748 Spanish. No abstract available.
Portal hypertension secondary to myelofibrosis: a study of three cases.
Alvarez-Larrán A, Abraldes JG, Cervantes F, Hernández-Guerra M, Vizzutti F, Miquel R, Gilabert R, Giusti M, Garcia-Pagan JC, Bosch J. Alvarez-Larrán A, et al. Am J Gastroenterol. 2005 Oct;100(10):2355-8. doi: 10.1111/j.1572-0241.2005.50374.x. Am J Gastroenterol. 2005. PMID: 16181389
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.
Harrison CN, Gupta VK, Gerds AT, Rampal R, Verstovsek S, Talpaz M, Kiladjian JJ, Mesa R, Kuykendall AT, Vannucchi AM, Palandri F, Grosicki S, Devos T, Jourdan E, Wondergem MJ, Al-Ali HK, Buxhofer-Ausch V, Alvarez-Larrán A, Patriarca A, Kremyanskaya M, Mead AJ, Akhani S, Sheikine Y, Colak G, Mascarenhas J. Harrison CN, et al. Future Oncol. 2022 Sep;18(27):2987-2997. doi: 10.2217/fon-2022-0484. Epub 2022 Aug 11. Future Oncol. 2022. PMID: 35950489 Free article.
160 results